In this study, with the preliminary observation that the level of FBXL16 in transgenic APP/PSEN mice decreased in an age-dependent manner, the molecular mechanism of FBXL16 in both in vivo and in vitro AD models was first investigated. This evidence concerns the gene FBXL16 and Alzheimer disease.